Generation of precursor T cells dor the development of adoptive T cell therapy for patients after stem cell transplantation.

Recruiting

• Conditions: Acute leukemia; blood cancer; 10027656

• Registration Number: NL-OMON36844
• Lead Sponsor: Medisch Universitair Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

Healthy volunteers, age ><=18<<= 60 year

Exclusion Criteria

Every chronical disease were G-CSF administration is a risk factor. More specific: Cardiovascular diseases, including hypertension, and malignancies.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Because there are no groups or populations in this study and only biological<br /><br>material (stem cells) is needed, there are no primary study parameters. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Because there are no groups or populations in this study and only biological<br /><br>material (stem cells) is needed, there are no secundary study parameters. </p><br>